A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I. - Eriksson, H; Wåhlander, K; Gustafsson, D (J Thromb Haemost, 2003)